NICOLE DEPUYT: Open Payments
NPI 1255940268 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,944 in 150 payments from 13 companies in 2025. Trend: 2023 $763 · 2024 $2,177 · 2025 $2,944
Food & beverage: $2,944
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $840 |
| Novo Nordisk Inc | 20 | $464 |
| ABBVIE INC. | 23 | $352 |
| PFIZER INC. | 23 | $312 |
| Braeburn Inc. | 8 | $230 |
| Phathom Pharmaceuticals, Inc. | 17 | $196 |
| GlaxoSmithKline, LLC. | 9 | $163 |
| Exact Sciences Corporation | 6 | $116 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Lilly USA, LLC | 5 | $86 |
Products named: AIRSUPRA, Ozempic, BREZTRI, BRIXADI, VOQUEZNA, VRAYLAR, TRELEGY ELLIPTA, UBRELVY.
Industry payments across NY — which companies pay providers there.
